U.S. Packaging Stock News

Recently released analysis shows that Selective Insurance Group has seen demand cool, with estimated 12‑month sales growth of just 1.7% alongside higher operating expenses and a 3.2 percentage point contraction in pre‑tax profit margins. Despite earnings per share growing 12.6% annually over the past two years, the stock’s 1.4x forward price‑to‑book multiple suggests investors remain cautious about the insurer’s current fundamentals. We’ll now explore how slowing demand and rising expenses...

Lululemon Athletica (LULU) opened fiscal Q1 2027 with total revenue of US$2.5b and basic EPS of US$1.70, alongside net income of US$195.0m, setting the tone for how the new year is starting after a busy 2026. The company has seen quarterly revenue move from US$2.4b and EPS of US$2.61 in Q1 2026 to US$2.5b and EPS of US$1.70 in Q1 2027, with trailing twelve month revenue at US$11.2b and EPS at US$12.76, which gives a fuller sense of scale. For investors, the focus now is on how these results...

Short term stock performance check Kodiak AI (KDK) has been on many watchlists after a weak share performance, with the stock down about 3% over the past week and about 17% over the past month. Looking further back, the stock has declined about 23% over the past 3 months and about 40% over the past year. This provides additional context for anyone tracking shorter term shifts. See our latest analysis for Kodiak AI. With the share price at $6.88 and the 1 year total shareholder return down...

Torrid Holdings (CURV) opened Q1 2027 with total revenue of US$245.8 million, basic EPS of roughly US$0.00, net income of US$0.4 million and same store sales that fell 1.7% year over year. Over recent quarters the company has seen revenue move from US$265.97 million in Q1 2026 to US$245.8 million in Q1 2027, while basic EPS shifted from about US$0.06 in Q1 2026 to roughly US$0.00 in the latest quarter. With the trailing twelve month line still showing a loss and revenue effectively flat, this...

This article examines whether Baxter International at around US$19.38 is a bargain or a value trap, by breaking down what the current price could be implying about the stock. The stock has risen 3.2% over the past week and 14.1% over the past month, yet it is still down 0.6% year to date and has fallen 35.4% over the last 12 months. Recent coverage of Baxter International has focused on its role in healthcare equipment and on how investors are reassessing companies in this part of the...

Why Danaher (DHR) is Drawing Investor Attention Now Danaher (DHR) is back in focus as investors reassess the company after a mixed stretch for the stock, including a decline year to date alongside modest recent gains over the past month. See our latest analysis for Danaher. Recent trading shows a 5.36% 30 day share price return, while the year to date share price return is down 20.01% and the 5 year total shareholder return is down 13.86%. This indicates that short term momentum is improving,...

Ferrellgas Partners (OTCPK:FGPR) has just posted its Q2 2026 numbers, with revenue of US$641.4 million and basic EPS of US$2.51. The trailing twelve month figures show revenue of about US$1.9 billion and basic EPS of US$1.31, as earnings have shifted from earlier losses into profit over the past year. Over recent quarters, revenue has ranged from US$343.6 million to US$669.8 million and basic EPS has swung between a loss of US$18.83 and a profit of US$2.51. This sets up a story where margins...

Recent performance snapshot Itron (ITRI) has been under pressure recently, with the stock down about 3% over the past month and about 12% over the past 3 months, and the one year total return down roughly 34%. At a recent close of US$80.07 and a market cap of about US$3.6b, the company reports annual revenue of US$2.35b and net income of US$289.04m, with yearly revenue and net income growth figures provided at 5.0% and 2.6% respectively. See our latest analysis for Itron. The recent share...

Exelixis reported new phase 3 CABINET trial data for CABOMETYX in advanced neuroendocrine tumors. The subgroup analysis showed significant improvements in progression free survival regardless of tumor functional status. These data were presented at ASCO 2026 and expand the evidence base for CABOMETYX in neuroendocrine tumors. For investors following NasdaqGS:EXEL, the CABINET subgroup results arrive with the stock at $52.7 and strong recent returns, including 20.9% year to date and 22.5%...

Recent stock performance and business context Arcus Biosciences (RCUS) has drawn attention after recent share price moves, with the stock down 6.1% on the day and about 10.8% over the past month, while still up over the past 3 months. At a recent close of US$23.19 and a market value of around US$3.1b, the company remains a clinical stage cancer therapy developer with revenue of US$236.0m and a reported net loss of US$369.0m. See our latest analysis for Arcus Biosciences. Recent moves have...

Recently, Zacks Investment Research upgraded Sharplink Inc. (SBET) to a Rank #2 (Buy), citing an upward trend in the company’s earnings estimates. This reassessment of Sharplink’s earnings outlook highlights how revisions in expectations can influence investor perception of the business’s longer-term potential. Next, we’ll explore how this improved earnings outlook, reflected in the Zacks upgrade, shapes Sharplink’s broader investment narrative. Invest in the nuclear renaissance through our...

Fresh Del Monte Produce (FDP) is in focus after its Del Monte Foods division announced a multi-year partnership with the Pittsburgh Pirates, while also naming Pittsburgh as the operational hub for its Foods Division. See our latest analysis for Fresh Del Monte Produce. The new Pittsburgh partnership comes after a tougher stretch for the stock, with the 30 day share price return down 21.28% and the 90 day share price return down 30.70%. The three year total shareholder return sits at 21.86%,...

Paramount Skydance's acquisition of Warner Bros. Discovery (NasdaqGS:WBD) is moving through global regulatory reviews, including a formal process in Europe. U.S. attorneys general are examining potential competition and industry impacts from the proposed Hollywood combination. Warner Bros. Discovery has reported a profitable streaming segment and recorded a substantial, one off merger related fee that resulted in a large loss. Warner Bros. Discovery, the media and entertainment group behind...

What is moving Antero Resources stock now? Antero Resources (AR) has drawn fresh attention after recent trading, with the stock closing at US$35.56. Investors are weighing that price against the company’s reported US$5.63b in revenue and US$961.66m in net income. See our latest analysis for Antero Resources. Recent trading has been choppy, with the 1-day share price return down 4.15% and the 90-day share price return down 8.42%, even though the year-to-date share price return is up 3.95%...

Wondering whether NVR at around US$6,182 per share is offering fair value or an opportunity? This article looks at what the current price really reflects. The stock has edged up 1.3% over the past week and 1.4% over the past month, yet is still down 15.1% year to date and 13.1% over the last year. This naturally raises questions about how the market is assessing its prospects and risks. Recent attention on NVR has focused on its broader sector context and housing market conditions, with...

Griffon stock snapshot Griffon (GFF) has caught investor attention after recent trading left the stock at a last close of US$85.50, with short term returns mixed and longer term performance data pointing to very different outcomes. See our latest analysis for Griffon. Recent trading has been choppy, with the share price down 7.65% over the past month but still showing a 13.94% year to date share price return and a 5 year total shareholder return of 309.16%. This points to momentum that has...

PENN Entertainment (NasdaqGS:PENN) is opening the new US$360 million Hollywood Casino Aurora as its latest land-based flagship in Illinois. The long-running Hollywood Casino riverboat in Aurora is set to close after more than 30 years of operation as activity shifts to the new property. The new complex combines gaming, hotel rooms, dining, and entertainment offerings in a single, purpose-built facility. The move reflects PENN Entertainment's push to grow its brick and mortar footprint...

If you are wondering whether AllianceBernstein Holding at around US$37.19 is attractively priced or asking too much for future returns, the starting point is understanding what the current valuation is actually baking in. The stock has been relatively steady over the past week with a 0.5% gain, while it has fallen 7.8% over the last month, is down 3.8% year to date, yet still shows a 2.4% return over one year, 39.4% over three years and 24.1% over five years. Recent coverage has focused on...

Transocean Ltd. reported that at its 2026 Annual General Meeting in May, shareholders approved amendments to its Articles of Association expanding flexibility to issue and manage share capital, while the company also secured a new multi-well contract for the Transocean Equinox rig supporting Santos and Carnarvon Energy’s 2027 exploration campaign offshore Western Australia. Together, the enhanced capital band and fresh Australian drilling work give Transocean more tools to fund operations...

Wondering if Cisco Systems at around US$130 is still good value after a strong run? This article will help you weigh what the current price actually reflects. The stock has logged returns of 9.6% over the past week, 37.9% over the past month, 71.0% year to date and 105.8% over the past year, as well as multi year returns of 184.3% over three years and 172.6% over five years. Recent coverage has focused on Cisco Systems as a large networking and security provider, with attention on how it...

Wondering if First Financial Bankshares at around US$32.35 is offering value or asking too much of your capital? This article focuses squarely on what the current share price might imply about the stock. The share price is up 7.8% year to date, even though the stock has fallen 1.1% over the last week and 7.0% over the past year, with a 29.9% decline across five years and a 17.2% gain across three years adding more mixed signals. Recent coverage has focused on the bank's positioning in its...

Bausch + Lomb (NYSE:BLCO) has launched Blink Triple Care Preservative Free eye drops in the U.S. The product is a preservative free, long lasting dry eye treatment available in a multi dose bottle. The launch expands the Blink brand within the competitive U.S. dry eye market. Bausch + Lomb, a long standing player in eye health, is adding Blink Triple Care Preservative Free to its U.S. product portfolio at a time when dry eye treatments are drawing more consumer attention. Patients and eye...

Calvin B. Taylor Bankshares (TYCB) kicked off Q1 2026 with total revenue of US$9.7 million and net income of US$3.8 million, translating into basic EPS of US$1.44, compared with Q1 2025 levels of US$9.6 million in revenue and US$3.7 million of net income, or EPS of US$1.36. Over the last twelve months, revenue has moved from US$35.7 million to US$39.2 million, while net income has gone from US$13.8 million to US$15.5 million and EPS has stepped up from US$5.05 to US$5.74. This gives investors...

Fluor (NYSE:FLR) received a US$1.03b contract modification from the U.S. Naval Sea Systems Command. The award supports the Naval Nuclear Laboratory and expands Fluor’s role in a major naval nuclear propulsion program. The contract modification is structured as a multi-year assignment focused on critical government work. For investors watching NYSE:FLR, this contract modification adds a large, long-duration project in U.S. defense alongside the company’s existing LNG and infrastructure work...